View Future GrowthK+S 과거 순이익 실적과거 기준 점검 0/6K+S 의 수입은 연평균 -39.8%의 비율로 감소해 온 반면, Chemicals 산업은 연평균 8%의 비율로 증가했습니다. 매출은 연평균 1.3%의 비율로 증가해 왔습니다.핵심 정보-39.76%순이익 성장률-40.58%주당순이익(EPS) 성장률Chemicals 산업 성장률23.20%매출 성장률1.27%자기자본이익률-27.81%순이익률-35.21%다음 순이익 업데이트12 Aug 2026최근 과거 실적 업데이트Reported Earnings • May 12First quarter 2026 earnings released: €0.88 loss per share (vs €0.48 profit in 1Q 2025)First quarter 2026 results: €0.88 loss per share (down from €0.48 profit in 1Q 2025). Revenue: €1.06b (up 10.0% from 1Q 2025). Net loss: €156.9m (down 284% from profit in 1Q 2025). Revenue is forecast to stay flat during the next 3 years compared to a 3.1% growth forecast for the Chemicals industry in Europe. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 128 percentage points per year, which is a significant difference in performance.공시 • May 12K+S Aktiengesellschaft to Report Q1, 2027 Results on May 11, 2027K+S Aktiengesellschaft announced that they will report Q1, 2027 results on May 11, 2027공시 • Mar 17K+S Aktiengesellschaft to Report Fiscal Year 2026 Results on Mar 11, 2027K+S Aktiengesellschaft announced that they will report fiscal year 2026 results at 7:00 AM, Central European Standard Time on Mar 11, 2027Reported Earnings • Mar 12Full year 2025 earnings released: €6.01 loss per share (vs €0.37 loss in FY 2024)Full year 2025 results: €6.01 loss per share (further deteriorated from €0.37 loss in FY 2024). Revenue: €3.65b (flat on FY 2024). Net loss: €1.08b (loss widened €1.01b from FY 2024). Revenue is forecast to grow 1.2% p.a. on average during the next 3 years, compared to a 6.7% growth forecast for the Chemicals industry in Italy. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 131 percentage points per year, which is a significant difference in performance.공시 • Nov 17K+S Aktiengesellschaft to Report Q3, 2026 Results on Nov 10, 2026K+S Aktiengesellschaft announced that they will report Q3, 2026 results at 7:00 AM, Central European Standard Time on Nov 10, 2026Reported Earnings • Nov 12Third quarter 2025 earnings released: EPS: €0.013 (vs €0.15 loss in 3Q 2024)Third quarter 2025 results: EPS: €0.013 (up from €0.15 loss in 3Q 2024). Revenue: €879.1m (up 1.5% from 3Q 2024). Net income: €2.30m (up €28.7m from 3Q 2024). Profit margin: 0.3% (up from net loss in 3Q 2024). The move to profitability was primarily driven by lower expenses. Revenue is forecast to grow 2.0% p.a. on average during the next 3 years, compared to a 7.7% growth forecast for the Chemicals industry in Italy. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 114 percentage points per year, which is a significant difference in performance.모든 업데이트 보기Recent updatesReported Earnings • May 12First quarter 2026 earnings released: €0.88 loss per share (vs €0.48 profit in 1Q 2025)First quarter 2026 results: €0.88 loss per share (down from €0.48 profit in 1Q 2025). Revenue: €1.06b (up 10.0% from 1Q 2025). Net loss: €156.9m (down 284% from profit in 1Q 2025). Revenue is forecast to stay flat during the next 3 years compared to a 3.1% growth forecast for the Chemicals industry in Europe. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 128 percentage points per year, which is a significant difference in performance.공시 • May 12K+S Aktiengesellschaft to Report Q1, 2027 Results on May 11, 2027K+S Aktiengesellschaft announced that they will report Q1, 2027 results on May 11, 2027Upcoming Dividend • May 06Upcoming dividend of €0.07 per shareEligible shareholders must have bought the stock before 13 May 2026. Payment date: 18 May 2026. The company is not currently making a profit and there are not enough cash flows to support it either. Trailing yield: 0.4%. Lower than top quartile of Italian dividend payers (4.6%). Lower than average of industry peers (3.3%).공시 • Apr 03K+S Aktiengesellschaft, Annual General Meeting, May 12, 2026K+S Aktiengesellschaft, Annual General Meeting, May 12, 2026, at 10:00 W. Europe Standard Time.New Risk • Mar 19New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Italian stocks, typically moving 6.1% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. This is currently the only risk that has been identified for the company.공시 • Mar 17K+S Aktiengesellschaft to Report Fiscal Year 2026 Results on Mar 11, 2027K+S Aktiengesellschaft announced that they will report fiscal year 2026 results at 7:00 AM, Central European Standard Time on Mar 11, 2027Declared Dividend • Mar 15Dividend reduced to €0.07Dividend of €0.07 is 53% lower than last year. Ex-date: 13th May 2026 Payment date: 15th May 2026 Dividend yield will be 0.4%, which is lower than the industry average of 2.8%.공시 • Mar 13K+S Aktiengesellschaft announces Annual dividend, payable on May 15, 2026K+S Aktiengesellschaft announced Annual dividend of EUR 0.0700 per share payable on May 15, 2026, ex-date on May 13, 2026 and record date on May 14, 2026.Reported Earnings • Mar 12Full year 2025 earnings released: €6.01 loss per share (vs €0.37 loss in FY 2024)Full year 2025 results: €6.01 loss per share (further deteriorated from €0.37 loss in FY 2024). Revenue: €3.65b (flat on FY 2024). Net loss: €1.08b (loss widened €1.01b from FY 2024). Revenue is forecast to grow 1.2% p.a. on average during the next 3 years, compared to a 6.7% growth forecast for the Chemicals industry in Italy. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 131 percentage points per year, which is a significant difference in performance.공시 • Nov 17K+S Aktiengesellschaft to Report Q3, 2026 Results on Nov 10, 2026K+S Aktiengesellschaft announced that they will report Q3, 2026 results at 7:00 AM, Central European Standard Time on Nov 10, 2026Reported Earnings • Nov 12Third quarter 2025 earnings released: EPS: €0.013 (vs €0.15 loss in 3Q 2024)Third quarter 2025 results: EPS: €0.013 (up from €0.15 loss in 3Q 2024). Revenue: €879.1m (up 1.5% from 3Q 2024). Net income: €2.30m (up €28.7m from 3Q 2024). Profit margin: 0.3% (up from net loss in 3Q 2024). The move to profitability was primarily driven by lower expenses. Revenue is forecast to grow 2.0% p.a. on average during the next 3 years, compared to a 7.7% growth forecast for the Chemicals industry in Italy. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 114 percentage points per year, which is a significant difference in performance.공시 • Aug 15K+S Aktiengesellschaft to Report Q2, 2026 Results on Aug 12, 2026K+S Aktiengesellschaft announced that they will report Q2, 2026 results on Aug 12, 2026Reported Earnings • Aug 13Second quarter 2025 earnings released: €9.68 loss per share (vs €0.034 loss in 2Q 2024)Second quarter 2025 results: €9.68 loss per share (further deteriorated from €0.034 loss in 2Q 2024). Revenue: €871.2m (flat on 2Q 2024). Net loss: €1.73b (loss widened €1.73b from 2Q 2024). Revenue is forecast to grow 2.5% p.a. on average during the next 3 years, compared to a 6.1% growth forecast for the Chemicals industry in Italy. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 104 percentage points per year, which is a significant difference in performance.공시 • May 15K+S Aktiengesellschaft to Report Q1, 2026 Results on May 11, 2026K+S Aktiengesellschaft announced that they will report Q1, 2026 results on May 11, 2026Reported Earnings • May 14First quarter 2025 earnings released: EPS: €0.48 (vs €0.10 in 1Q 2024)First quarter 2025 results: EPS: €0.48 (up from €0.10 in 1Q 2024). Revenue: €964.7m (down 2.4% from 1Q 2024). Net income: €85.5m (up 360% from 1Q 2024). Profit margin: 8.9% (up from 1.9% in 1Q 2024). Revenue is forecast to grow 1.9% p.a. on average during the next 3 years, compared to a 6.1% growth forecast for the Chemicals industry in Italy. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 82 percentage points per year, which is a significant difference in performance.Upcoming Dividend • May 08Upcoming dividend of €0.15 per shareEligible shareholders must have bought the stock before 15 May 2025. Payment date: 19 May 2025. The company is not currently making a profit but it is cash flow positive. Trailing yield: 1.0%. Lower than top quartile of Italian dividend payers (5.6%). Lower than average of industry peers (2.6%).Declared Dividend • Apr 07Dividend reduced to €0.15Dividend of €0.15 is 79% lower than last year. Ex-date: 15th May 2025 Payment date: 19th May 2025 Dividend yield will be 1.2%, which is lower than the industry average of 2.8%. Sustainability & Growth Dividend is being paid despite the company being loss-making over the last 12 months. However, the dividend is well covered by cash flows (39% cash payout ratio). The dividend has decreased over the past 10 years, indicating a lack of growth and stability in payments.공시 • Apr 03+ 1 more updateK+S Aktiengesellschaft, Annual General Meeting, May 14, 2025K+S Aktiengesellschaft, Annual General Meeting, May 14, 2025, at 10:00 W. Europe Standard Time.공시 • Mar 15K+S Aktiengesellschaft to Report Fiscal Year 2025 Results on Mar 12, 2026K+S Aktiengesellschaft announced that they will report fiscal year 2025 results on Mar 12, 2026Reported Earnings • Mar 13Full year 2024 earnings released: EPS: €1.12 (vs €1.12 in FY 2023)Full year 2024 results: EPS: €1.12 (down from €1.12 in FY 2023). Revenue: €3.65b (down 5.7% from FY 2023). Net loss: €66.8m (down 132% from profit in FY 2023). Revenue is forecast to stay flat during the next 3 years compared to a 6.4% growth forecast for the Chemicals industry in Italy. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 65 percentage points per year, which is a significant difference in performance.New Risk • Jan 31New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Italian stocks, typically moving 5.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Dividend is not well covered by earnings and cash flows. Payout ratio: 491% Cash payout ratio: 103% Minor Risks Share price has been volatile over the past 3 months (5.6% average weekly change). Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (0.7% net profit margin).New Risk • Nov 15New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Italian stocks, typically moving 5.2% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Dividend is not well covered by earnings and cash flows. Payout ratio: 491% Cash payout ratio: 103% Minor Risks Share price has been volatile over the past 3 months (5.2% average weekly change). Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (0.7% net profit margin).Reported Earnings • Nov 15Third quarter 2024 earnings released: €0.15 loss per share (vs €0.26 loss in 3Q 2023)Third quarter 2024 results: €0.15 loss per share (improved from €0.26 loss in 3Q 2023). Revenue: €866.2m (down 1.7% from 3Q 2023). Net loss: €26.4m (loss narrowed 45% from 3Q 2023). Revenue is forecast to stay flat during the next 3 years compared to a 7.8% growth forecast for the Chemicals industry in Italy. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 63 percentage points per year, which is a significant difference in performance.공시 • Nov 15K+S Aktiengesellschaft to Report Q3, 2025 Results on Nov 11, 2025K+S Aktiengesellschaft announced that they will report Q3, 2025 results on Nov 11, 2025공시 • Oct 24+ 1 more updateK+S Group Announces CFO Changes, Effective June 1, 2025K+S Group(SDFG) appointed Jens Christian Keuthen, currently Head of Legal, Tax, Regulatory Affairs, and New Business Areas at K+S, as CFO. Company appointed Chief Financial Officer Christian Meyer as the Chairman of the Board. All new appointments are effective from June 1, 2025.Reported Earnings • Aug 15Second quarter 2024 earnings released: €0.034 loss per share (vs €0.24 loss in 2Q 2023)Second quarter 2024 results: €0.034 loss per share (improved from €0.24 loss in 2Q 2023). Revenue: €873.8m (up 5.8% from 2Q 2023). Net loss: €6.10m (loss narrowed 87% from 2Q 2023). Revenue is forecast to grow 1.2% p.a. on average during the next 3 years, compared to a 7.9% growth forecast for the Chemicals industry in Italy. Over the last 3 years on average, earnings per share has fallen by 25% per year but the company’s share price has increased by 1% per year, which means it is well ahead of earnings.공시 • Aug 14K+S Aktiengesellschaft to Report Q2, 2025 Results on Aug 12, 2025K+S Aktiengesellschaft announced that they will report Q2, 2025 results on Aug 12, 2025공시 • May 14K+S Aktiengesellschaft to Report Q1, 2025 Results on May 13, 2025K+S Aktiengesellschaft announced that they will report Q1, 2025 results on May 13, 2025Reported Earnings • May 13First quarter 2024 earnings released: EPS: €0.10 (vs €1.38 in 1Q 2023)First quarter 2024 results: EPS: €0.10 (down from €1.38 in 1Q 2023). Revenue: €988.0m (down 17% from 1Q 2023). Net income: €18.6m (down 93% from 1Q 2023). Profit margin: 1.9% (down from 22% in 1Q 2023). Revenue is forecast to grow 1.1% p.a. on average during the next 3 years, compared to a 7.9% growth forecast for the Chemicals industry in Italy. Over the last 3 years on average, earnings per share has increased by 14% per year whereas the company’s share price has increased by 12% per year.Declared Dividend • Mar 17Dividend of €0.70 announcedShareholders will receive a dividend of €0.70. Ex-date: 15th May 2024 Payment date: 17th May 2024 Dividend yield will be 5.3%, which is higher than the industry average of 2.8%. Sustainability & Growth Dividend is covered by both earnings (62% earnings payout ratio) and cash flows (37% cash payout ratio). The dividend has increased by an average of 11% per year over the past 10 years. However, payments have been volatile during that time. EPS is expected to decline by 65% over the next 3 years. Since a fall of 31% would increase the payout ratio to a potentially unsustainable range, the dividend may be at risk.공시 • Mar 15K+S Aktiengesellschaft to Report Fiscal Year 2024 Results on Mar 13, 2025K+S Aktiengesellschaft announced that they will report fiscal year 2024 results on Mar 13, 2025Reported Earnings • Mar 15Full year 2023 earnings released: EPS: €1.12 (vs €7.88 in FY 2022)Full year 2023 results: EPS: €1.12 (down from €7.88 in FY 2022). Revenue: €3.87b (down 32% from FY 2022). Net income: €209.9m (down 86% from FY 2022). Profit margin: 5.4% (down from 27% in FY 2022). The decrease in margin was driven by lower revenue. Revenue is forecast to stay flat during the next 3 years compared to a 5.7% growth forecast for the Chemicals industry in Italy. Over the last 3 years on average, earnings per share has increased by 46% per year but the company’s share price has only increased by 16% per year, which means it is significantly lagging earnings growth.Valuation Update With 7 Day Price Move • Jan 08Investor sentiment deteriorates as stock falls 15%After last week's 15% share price decline to €13.77, the stock trades at a forward P/E ratio of 15x. Average forward P/E is 16x in the Chemicals industry in Europe. Total returns to shareholders of 49% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €8.84 per share.공시 • Nov 24+ 1 more updateK+S Aktiengesellschaft to Report Q3, 2024 Results on Nov 14, 2024K+S Aktiengesellschaft announced that they will report Q3, 2024 results at 7:00 AM, Central European Standard Time on Nov 14, 2024Reported Earnings • Nov 15Third quarter 2023 earnings released: €0.25 loss per share (vs €1.48 profit in 3Q 2022)Third quarter 2023 results: €0.25 loss per share (down from €1.48 profit in 3Q 2022). Revenue: €880.8m (down 40% from 3Q 2022). Net loss: €47.6m (down 117% from profit in 3Q 2022). Revenue is expected to decline by 3.5% p.a. on average during the next 3 years, while revenues in the Chemicals industry in Italy are expected to grow by 6.1%. Over the last 3 years on average, earnings per share has increased by 69% per year but the company’s share price has only increased by 30% per year, which means it is significantly lagging earnings growth.공시 • Aug 15K+S Aktiengesellschaft to Report Q1, 2024 Results on May 13, 2024K+S Aktiengesellschaft announced that they will report Q1, 2024 results at 7:00 AM, Central European Standard Time on May 13, 2024Reported Earnings • Aug 13Second quarter 2023 earnings released: €0.24 loss per share (vs €1.94 profit in 2Q 2022)Second quarter 2023 results: €0.24 loss per share (down from €1.94 profit in 2Q 2022). Revenue: €825.8m (down 45% from 2Q 2022). Net loss: €45.3m (down 112% from profit in 2Q 2022). Revenue is expected to decline by 4.1% p.a. on average during the next 3 years, while revenues in the Chemicals industry in Europe are expected to grow by 3.1%. Over the last 3 years on average, earnings per share has increased by 76% per year but the company’s share price has only increased by 44% per year, which means it is significantly lagging earnings growth.공시 • Aug 11K+S Aktiengesellschaft to Report Q2, 2024 Results on Aug 14, 2024K+S Aktiengesellschaft announced that they will report Q2, 2024 results on Aug 14, 2024New Risk • Jul 20New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Italian stocks, typically moving 4.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings are forecast to decline by an average of 78% per year for the foreseeable future. Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Share price has been volatile over the past 3 months (4.8% average weekly change). Profit margins are more than 30% lower than last year (26% net profit margin).Upcoming Dividend • May 04Upcoming dividend of €1.00 per share at 5.8% yieldEligible shareholders must have bought the stock before 11 May 2023. Payment date: 15 May 2023. Payout ratio is a comfortable 13% and this is well supported by cash flows. Trailing yield: 5.8%. Within top quartile of Italian dividend payers (5.2%). Higher than average of industry peers (3.9%).Reported Earnings • Mar 16Full year 2022 earnings released: EPS: €7.88 (vs €11.35 in FY 2021)Full year 2022 results: EPS: €7.88 (down from €11.35 in FY 2021). Revenue: €5.68b (up 77% from FY 2021). Net income: €1.51b (down 31% from FY 2021). Profit margin: 27% (down from 68% in FY 2021). The decrease in margin was driven by higher expenses. Revenue is expected to decline by 6.9% p.a. on average during the next 3 years, while revenues in the Chemicals industry in Europe are expected to grow by 2.6%. Over the last 3 years on average, earnings per share has increased by 79% per year but the company’s share price has only increased by 45% per year, which means it is significantly lagging earnings growth.공시 • Jan 27K+S Aktiengesellschaft (XTRA:SDF) agreed to acquire 75% stake in Fertilizer business of Industrial Commodities Holdings (Pty) Ltd (ICH).K+S Aktiengesellschaft (XTRA:SDF) agreed to acquire 75% stake in Fertilizer business of Industrial Commodities Holdings (Pty) Ltd (ICH) on January 26, 2023. The new business will operate under the name Fertiva (Pty) Ltd. The balance of 25% of shares in Fertiva will be held by two former ICH shareholders, who will now be a part of the Fertiva management team. The closing of the transaction remains subject to the fulfillment of a number of conditions, including obtaining required regulatory approvals and is expected to close during the second quarter of 2023.공시 • Jan 22K+S Aktiengesellschaft Appoints Carin-Martina Tröltzsch as Member of the Board of Executive Directors, Effective March 15, 2023The Supervisory Board of K+S Aktiengesellschaft has appointed Dr. Carin-Martina Tröltzsch as a further member of the Board of Executive Directors of the Company. She will assume her position at K+S on March 15, 2023. Dr. Christian H. Meyer, who was already appointed as the new Chief Financial Officer by the Supervisory Board of the Company in February of last year, will also take up his position on March 15, 2023, and will be responsible for the management and further development of the finance area at K+S. Dr. Burkhard Lohr, Chairman of the Board of Executive Directors, had assumed this role on a transitional basis in recent months.공시 • Nov 13K+S Aktiengesellschaft to Report Q3, 2022 Results on Nov 14, 2023K+S Aktiengesellschaft announced that they will report Q3, 2022 results at 7:00 AM, Central European Standard Time on Nov 14, 2023Reported Earnings • Aug 12Second quarter 2022 earnings released: EPS: €1.93 (vs €0.78 in 2Q 2021)Second quarter 2022 results: EPS: €1.93 (up from €0.78 in 2Q 2021). Revenue: €1.51b (up 127% from 2Q 2021). Net income: €370.3m (up 147% from 2Q 2021). Profit margin: 25% (up from 23% in 2Q 2021). Over the next year, revenue is forecast to grow 16%, compared to a 14% growth forecast for the industry in Italy. Over the last 3 years on average, earnings per share has increased by 65% per year but the company’s share price has only increased by 16% per year, which means it is significantly lagging earnings growth.공시 • Aug 12K+S Aktiengesellschaft to Report Q2, 2023 Results on Aug 10, 2023K+S Aktiengesellschaft announced that they will report Q2, 2023 results on Aug 10, 2023Reported Earnings • May 13First quarter 2022 earnings releasedFirst quarter 2022 results: Revenue: €1.21b (up 65% from 1Q 2021). Net income: €310.9m (up 44% from 1Q 2021). Profit margin: 26% (down from 29% in 1Q 2021). Over the next year, revenue is forecast to grow 46%, compared to a 17% growth forecast for the industry in Italy.공시 • May 12K+S Aktiengesellschaft to Report Q1, 2023 Results on May 09, 2023K+S Aktiengesellschaft announced that they will report Q1, 2023 results on May 09, 2023Upcoming Dividend • May 06Upcoming dividend of €0.20 per shareEligible shareholders must have bought the stock before 13 May 2022. Payment date: 17 May 2022. Trailing yield: 0.6%. Lower than top quartile of Italian dividend payers (4.8%). Lower than average of industry peers (3.3%).Valuation Update With 7 Day Price Move • Apr 11Investor sentiment improved over the past weekAfter last week's 17% share price gain to €32.67, the stock trades at a forward P/E ratio of 5x. Average forward P/E is 15x in the Chemicals industry in Europe. Total returns to shareholders of 84% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €33.62 per share.Buying Opportunity • Mar 29Now 22% undervaluedOver the last 90 days, the stock is up 67%. The fair value is estimated to be €32.95, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 18% per annum over the last 3 years. The company has become profitable over the last year.Valuation Update With 7 Day Price Move • Mar 21Investor sentiment improved over the past weekAfter last week's 18% share price gain to €27.62, the stock trades at a forward P/E ratio of 5x. Average forward P/E is 15x in the Chemicals industry in Europe. Total returns to shareholders of 66% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €33.10 per share.Reported Earnings • Mar 11Full year 2021 earnings: EPS in line with analyst expectations despite revenue beatFull year 2021 results: EPS: €11.36 (up from €9.88 loss in FY 2020). Revenue: €3.21b (up 32% from FY 2020). Net income: €2.17b (up €4.06b from FY 2020). Profit margin: 68% (up from net loss in FY 2020). The move to profitability was primarily driven by lower expenses. Revenue exceeded analyst estimates by 2.3%. Over the next year, revenue is forecast to grow 28%, compared to a 12% growth forecast for the industry in Italy. Over the last 3 years on average, earnings per share has increased by 8% per year but the company’s share price has increased by 17% per year, which means it is tracking significantly ahead of earnings growth.Valuation Update With 7 Day Price Move • Mar 02Investor sentiment improved over the past weekAfter last week's 16% share price gain to €23.69, the stock trades at a forward P/E ratio of 4x. Average forward P/E is 16x in the Chemicals industry in Europe. Total returns to shareholders of 45% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €26.40 per share.Reported Earnings • Nov 15Third quarter 2021 earnings released: EPS €6.64 (vs €10.26 loss in 3Q 2020)Third quarter 2021 results: Revenue: €746.3m (down 9.2% from 3Q 2020). Net income: €1.27b (up €3.23b from 3Q 2020). Over the last 3 years on average, earnings per share has fallen by 43% per year but the company’s share price has only fallen by 5% per year, which means it has not declined as severely as earnings.Reported Earnings • Aug 18Second quarter 2021 earnings released: EPS €0.78 (vs €0.019 loss in 2Q 2020)The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: €664.2m (up 13% from 2Q 2020). Net income: €149.9m (up €153.6m from 2Q 2020). Profit margin: 23% (up from net loss in 2Q 2020). The move to profitability was primarily driven by lower expenses. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 102 percentage points per year, which is a significant difference in performance.Reported Earnings • May 14First quarter 2021 earnings released: EPS €1.13 (vs €0.33 loss in 1Q 2020)The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2021 results: Revenue: €733.3m (up 13% from 1Q 2020). Net income: €215.7m (up €278.9m from 1Q 2020). Profit margin: 29% (up from net loss in 1Q 2020). The move to profitability was primarily driven by lower expenses. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 104 percentage points per year, which is a significant difference in performance.Is New 90 Day High Low • Jan 04New 90-day high: €8.44The company is up 19% from its price of €7.10 on 06 October 2020. The Italian market is up 13% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 6.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €4.87 per share.Is New 90 Day High Low • Nov 27New 90-day high: €7.81The company is up 26% from its price of €6.19 on 28 August 2020. The Italian market is up 10.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 4.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €18.95 per share.Reported Earnings • Nov 13Third quarter 2020 earnings released: €10.26 loss per shareThe company reported a poor third quarter result with increased losses and weaker revenues and control over expenses. Third quarter 2020 results: Revenue: €821.7m (down 9.2% from 3Q 2019). Net loss: €1.96b (loss widened €1.91b from 3Q 2019). Over the last 3 years on average, earnings per share has fallen by 132% per year but the company’s share price has only fallen by 32% per year, which means it has not declined as severely as earnings.Analyst Estimate Surprise Post Earnings • Nov 13Revenue misses expectationsRevenue missed analyst estimates by 1.4%. Over the next year, revenue is forecast to grow 3.2% while the growth in Chemicals industry in Italy is expected to stay flat.Is New 90 Day High Low • Sep 22New 90-day low: €5.25The company is down 10.0% from its price of €5.85 on 24 June 2020. The Italian market is down 1.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 10.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €16.81 per share.매출 및 비용 세부 내역K+S가 돈을 벌고 사용하는 방법. 최근 발표된 LTM 실적 기준.순이익 및 매출 추이BIT:1SDF 매출, 비용 및 순이익 (EUR Millions)날짜매출순이익일반관리비연구개발비31 Mar 263,744-1,318196031 Dec 253,648-1,076195030 Sep 253,640-1,699196030 Jun 253,627-1,728192031 Mar 253,6300189031 Dec 243,653-67187030 Sep 243,70226189030 Jun 243,7174185031 Mar 243,669-35187031 Dec 233,873210188030 Sep 234,383715190030 Jun 234,9721,045186031 Mar 235,6561,461185031 Dec 225,6771,508186030 Sep 225,2621,462194030 Jun 224,5382,450195031 Mar 223,6922,229180031 Dec 213,2132,134176030 Sep 212,7721,559180030 Jun 212,592-1,458178031 Mar 212,518-1,612192031 Dec 202,432-1,891197030 Sep 201,306-1,85340030 Jun 201,645-163100031 Mar 201,933-145141031 Dec 192,55027172030 Sep 194,264127361030 Jun 194,199121344031 Mar 194,13375346031 Dec 184,03942350030 Sep 183,85413537430 Jun 183,74089641831 Mar 183,6701597581131 Dec 173,6271859361730 Sep 173,5361548341630 Jun 173,4971138581631 Mar 173,488758721631 Dec 163,4571748711430 Sep 163,5083029681430 Jun 163,7123809891431 Mar 163,8945331,0111531 Dec 154,1764951,0481530 Sep 154,2034281,0341430 Jun 154,1394671,02014양질의 수익: 1SDF 은(는) 현재 수익성이 없습니다.이익 마진 증가: 1SDF는 현재 수익성이 없습니다.잉여현금흐름 대비 순이익 분석과거 순이익 성장 분석수익추이: 1SDF은 수익성이 없으며 지난 5년 동안 손실이 연평균 39.8% 증가했습니다.성장 가속화: 현재 수익성이 없어 지난 1년간 1SDF의 수익 성장률을 5년 평균과 비교할 수 없습니다.수익 대 산업: 1SDF은 수익성이 없어 지난 해 수익 성장률을 Chemicals 업계(-36.9%)와 비교하기 어렵습니다.자기자본이익률높은 ROE: 1SDF는 현재 수익성이 없으므로 자본 수익률이 음수(-27.81%)입니다.총자산이익률투하자본수익률우수한 과거 실적 기업을 찾아보세요7D1Y7D1Y7D1YMaterials 산업에서 과거 실적이 우수한 기업.View Financial Health기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/05/24 16:18종가2026/05/22 00:00수익2026/03/31연간 수익2025/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스K+S Aktiengesellschaft는 43명의 분석가가 다루고 있습니다. 이 중 14명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관Stephen WilderAlliance Global PartnersKonstantin WiechertBaader Helvea Equity ResearchKnut WollerBaader Helvea Equity Research40명의 분석가 더 보기
Reported Earnings • May 12First quarter 2026 earnings released: €0.88 loss per share (vs €0.48 profit in 1Q 2025)First quarter 2026 results: €0.88 loss per share (down from €0.48 profit in 1Q 2025). Revenue: €1.06b (up 10.0% from 1Q 2025). Net loss: €156.9m (down 284% from profit in 1Q 2025). Revenue is forecast to stay flat during the next 3 years compared to a 3.1% growth forecast for the Chemicals industry in Europe. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 128 percentage points per year, which is a significant difference in performance.
공시 • May 12K+S Aktiengesellschaft to Report Q1, 2027 Results on May 11, 2027K+S Aktiengesellschaft announced that they will report Q1, 2027 results on May 11, 2027
공시 • Mar 17K+S Aktiengesellschaft to Report Fiscal Year 2026 Results on Mar 11, 2027K+S Aktiengesellschaft announced that they will report fiscal year 2026 results at 7:00 AM, Central European Standard Time on Mar 11, 2027
Reported Earnings • Mar 12Full year 2025 earnings released: €6.01 loss per share (vs €0.37 loss in FY 2024)Full year 2025 results: €6.01 loss per share (further deteriorated from €0.37 loss in FY 2024). Revenue: €3.65b (flat on FY 2024). Net loss: €1.08b (loss widened €1.01b from FY 2024). Revenue is forecast to grow 1.2% p.a. on average during the next 3 years, compared to a 6.7% growth forecast for the Chemicals industry in Italy. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 131 percentage points per year, which is a significant difference in performance.
공시 • Nov 17K+S Aktiengesellschaft to Report Q3, 2026 Results on Nov 10, 2026K+S Aktiengesellschaft announced that they will report Q3, 2026 results at 7:00 AM, Central European Standard Time on Nov 10, 2026
Reported Earnings • Nov 12Third quarter 2025 earnings released: EPS: €0.013 (vs €0.15 loss in 3Q 2024)Third quarter 2025 results: EPS: €0.013 (up from €0.15 loss in 3Q 2024). Revenue: €879.1m (up 1.5% from 3Q 2024). Net income: €2.30m (up €28.7m from 3Q 2024). Profit margin: 0.3% (up from net loss in 3Q 2024). The move to profitability was primarily driven by lower expenses. Revenue is forecast to grow 2.0% p.a. on average during the next 3 years, compared to a 7.7% growth forecast for the Chemicals industry in Italy. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 114 percentage points per year, which is a significant difference in performance.
Reported Earnings • May 12First quarter 2026 earnings released: €0.88 loss per share (vs €0.48 profit in 1Q 2025)First quarter 2026 results: €0.88 loss per share (down from €0.48 profit in 1Q 2025). Revenue: €1.06b (up 10.0% from 1Q 2025). Net loss: €156.9m (down 284% from profit in 1Q 2025). Revenue is forecast to stay flat during the next 3 years compared to a 3.1% growth forecast for the Chemicals industry in Europe. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 128 percentage points per year, which is a significant difference in performance.
공시 • May 12K+S Aktiengesellschaft to Report Q1, 2027 Results on May 11, 2027K+S Aktiengesellschaft announced that they will report Q1, 2027 results on May 11, 2027
Upcoming Dividend • May 06Upcoming dividend of €0.07 per shareEligible shareholders must have bought the stock before 13 May 2026. Payment date: 18 May 2026. The company is not currently making a profit and there are not enough cash flows to support it either. Trailing yield: 0.4%. Lower than top quartile of Italian dividend payers (4.6%). Lower than average of industry peers (3.3%).
공시 • Apr 03K+S Aktiengesellschaft, Annual General Meeting, May 12, 2026K+S Aktiengesellschaft, Annual General Meeting, May 12, 2026, at 10:00 W. Europe Standard Time.
New Risk • Mar 19New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Italian stocks, typically moving 6.1% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. This is currently the only risk that has been identified for the company.
공시 • Mar 17K+S Aktiengesellschaft to Report Fiscal Year 2026 Results on Mar 11, 2027K+S Aktiengesellschaft announced that they will report fiscal year 2026 results at 7:00 AM, Central European Standard Time on Mar 11, 2027
Declared Dividend • Mar 15Dividend reduced to €0.07Dividend of €0.07 is 53% lower than last year. Ex-date: 13th May 2026 Payment date: 15th May 2026 Dividend yield will be 0.4%, which is lower than the industry average of 2.8%.
공시 • Mar 13K+S Aktiengesellschaft announces Annual dividend, payable on May 15, 2026K+S Aktiengesellschaft announced Annual dividend of EUR 0.0700 per share payable on May 15, 2026, ex-date on May 13, 2026 and record date on May 14, 2026.
Reported Earnings • Mar 12Full year 2025 earnings released: €6.01 loss per share (vs €0.37 loss in FY 2024)Full year 2025 results: €6.01 loss per share (further deteriorated from €0.37 loss in FY 2024). Revenue: €3.65b (flat on FY 2024). Net loss: €1.08b (loss widened €1.01b from FY 2024). Revenue is forecast to grow 1.2% p.a. on average during the next 3 years, compared to a 6.7% growth forecast for the Chemicals industry in Italy. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 131 percentage points per year, which is a significant difference in performance.
공시 • Nov 17K+S Aktiengesellschaft to Report Q3, 2026 Results on Nov 10, 2026K+S Aktiengesellschaft announced that they will report Q3, 2026 results at 7:00 AM, Central European Standard Time on Nov 10, 2026
Reported Earnings • Nov 12Third quarter 2025 earnings released: EPS: €0.013 (vs €0.15 loss in 3Q 2024)Third quarter 2025 results: EPS: €0.013 (up from €0.15 loss in 3Q 2024). Revenue: €879.1m (up 1.5% from 3Q 2024). Net income: €2.30m (up €28.7m from 3Q 2024). Profit margin: 0.3% (up from net loss in 3Q 2024). The move to profitability was primarily driven by lower expenses. Revenue is forecast to grow 2.0% p.a. on average during the next 3 years, compared to a 7.7% growth forecast for the Chemicals industry in Italy. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 114 percentage points per year, which is a significant difference in performance.
공시 • Aug 15K+S Aktiengesellschaft to Report Q2, 2026 Results on Aug 12, 2026K+S Aktiengesellschaft announced that they will report Q2, 2026 results on Aug 12, 2026
Reported Earnings • Aug 13Second quarter 2025 earnings released: €9.68 loss per share (vs €0.034 loss in 2Q 2024)Second quarter 2025 results: €9.68 loss per share (further deteriorated from €0.034 loss in 2Q 2024). Revenue: €871.2m (flat on 2Q 2024). Net loss: €1.73b (loss widened €1.73b from 2Q 2024). Revenue is forecast to grow 2.5% p.a. on average during the next 3 years, compared to a 6.1% growth forecast for the Chemicals industry in Italy. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 104 percentage points per year, which is a significant difference in performance.
공시 • May 15K+S Aktiengesellschaft to Report Q1, 2026 Results on May 11, 2026K+S Aktiengesellschaft announced that they will report Q1, 2026 results on May 11, 2026
Reported Earnings • May 14First quarter 2025 earnings released: EPS: €0.48 (vs €0.10 in 1Q 2024)First quarter 2025 results: EPS: €0.48 (up from €0.10 in 1Q 2024). Revenue: €964.7m (down 2.4% from 1Q 2024). Net income: €85.5m (up 360% from 1Q 2024). Profit margin: 8.9% (up from 1.9% in 1Q 2024). Revenue is forecast to grow 1.9% p.a. on average during the next 3 years, compared to a 6.1% growth forecast for the Chemicals industry in Italy. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 82 percentage points per year, which is a significant difference in performance.
Upcoming Dividend • May 08Upcoming dividend of €0.15 per shareEligible shareholders must have bought the stock before 15 May 2025. Payment date: 19 May 2025. The company is not currently making a profit but it is cash flow positive. Trailing yield: 1.0%. Lower than top quartile of Italian dividend payers (5.6%). Lower than average of industry peers (2.6%).
Declared Dividend • Apr 07Dividend reduced to €0.15Dividend of €0.15 is 79% lower than last year. Ex-date: 15th May 2025 Payment date: 19th May 2025 Dividend yield will be 1.2%, which is lower than the industry average of 2.8%. Sustainability & Growth Dividend is being paid despite the company being loss-making over the last 12 months. However, the dividend is well covered by cash flows (39% cash payout ratio). The dividend has decreased over the past 10 years, indicating a lack of growth and stability in payments.
공시 • Apr 03+ 1 more updateK+S Aktiengesellschaft, Annual General Meeting, May 14, 2025K+S Aktiengesellschaft, Annual General Meeting, May 14, 2025, at 10:00 W. Europe Standard Time.
공시 • Mar 15K+S Aktiengesellschaft to Report Fiscal Year 2025 Results on Mar 12, 2026K+S Aktiengesellschaft announced that they will report fiscal year 2025 results on Mar 12, 2026
Reported Earnings • Mar 13Full year 2024 earnings released: EPS: €1.12 (vs €1.12 in FY 2023)Full year 2024 results: EPS: €1.12 (down from €1.12 in FY 2023). Revenue: €3.65b (down 5.7% from FY 2023). Net loss: €66.8m (down 132% from profit in FY 2023). Revenue is forecast to stay flat during the next 3 years compared to a 6.4% growth forecast for the Chemicals industry in Italy. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 65 percentage points per year, which is a significant difference in performance.
New Risk • Jan 31New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Italian stocks, typically moving 5.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Dividend is not well covered by earnings and cash flows. Payout ratio: 491% Cash payout ratio: 103% Minor Risks Share price has been volatile over the past 3 months (5.6% average weekly change). Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (0.7% net profit margin).
New Risk • Nov 15New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Italian stocks, typically moving 5.2% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Dividend is not well covered by earnings and cash flows. Payout ratio: 491% Cash payout ratio: 103% Minor Risks Share price has been volatile over the past 3 months (5.2% average weekly change). Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (0.7% net profit margin).
Reported Earnings • Nov 15Third quarter 2024 earnings released: €0.15 loss per share (vs €0.26 loss in 3Q 2023)Third quarter 2024 results: €0.15 loss per share (improved from €0.26 loss in 3Q 2023). Revenue: €866.2m (down 1.7% from 3Q 2023). Net loss: €26.4m (loss narrowed 45% from 3Q 2023). Revenue is forecast to stay flat during the next 3 years compared to a 7.8% growth forecast for the Chemicals industry in Italy. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 63 percentage points per year, which is a significant difference in performance.
공시 • Nov 15K+S Aktiengesellschaft to Report Q3, 2025 Results on Nov 11, 2025K+S Aktiengesellschaft announced that they will report Q3, 2025 results on Nov 11, 2025
공시 • Oct 24+ 1 more updateK+S Group Announces CFO Changes, Effective June 1, 2025K+S Group(SDFG) appointed Jens Christian Keuthen, currently Head of Legal, Tax, Regulatory Affairs, and New Business Areas at K+S, as CFO. Company appointed Chief Financial Officer Christian Meyer as the Chairman of the Board. All new appointments are effective from June 1, 2025.
Reported Earnings • Aug 15Second quarter 2024 earnings released: €0.034 loss per share (vs €0.24 loss in 2Q 2023)Second quarter 2024 results: €0.034 loss per share (improved from €0.24 loss in 2Q 2023). Revenue: €873.8m (up 5.8% from 2Q 2023). Net loss: €6.10m (loss narrowed 87% from 2Q 2023). Revenue is forecast to grow 1.2% p.a. on average during the next 3 years, compared to a 7.9% growth forecast for the Chemicals industry in Italy. Over the last 3 years on average, earnings per share has fallen by 25% per year but the company’s share price has increased by 1% per year, which means it is well ahead of earnings.
공시 • Aug 14K+S Aktiengesellschaft to Report Q2, 2025 Results on Aug 12, 2025K+S Aktiengesellschaft announced that they will report Q2, 2025 results on Aug 12, 2025
공시 • May 14K+S Aktiengesellschaft to Report Q1, 2025 Results on May 13, 2025K+S Aktiengesellschaft announced that they will report Q1, 2025 results on May 13, 2025
Reported Earnings • May 13First quarter 2024 earnings released: EPS: €0.10 (vs €1.38 in 1Q 2023)First quarter 2024 results: EPS: €0.10 (down from €1.38 in 1Q 2023). Revenue: €988.0m (down 17% from 1Q 2023). Net income: €18.6m (down 93% from 1Q 2023). Profit margin: 1.9% (down from 22% in 1Q 2023). Revenue is forecast to grow 1.1% p.a. on average during the next 3 years, compared to a 7.9% growth forecast for the Chemicals industry in Italy. Over the last 3 years on average, earnings per share has increased by 14% per year whereas the company’s share price has increased by 12% per year.
Declared Dividend • Mar 17Dividend of €0.70 announcedShareholders will receive a dividend of €0.70. Ex-date: 15th May 2024 Payment date: 17th May 2024 Dividend yield will be 5.3%, which is higher than the industry average of 2.8%. Sustainability & Growth Dividend is covered by both earnings (62% earnings payout ratio) and cash flows (37% cash payout ratio). The dividend has increased by an average of 11% per year over the past 10 years. However, payments have been volatile during that time. EPS is expected to decline by 65% over the next 3 years. Since a fall of 31% would increase the payout ratio to a potentially unsustainable range, the dividend may be at risk.
공시 • Mar 15K+S Aktiengesellschaft to Report Fiscal Year 2024 Results on Mar 13, 2025K+S Aktiengesellschaft announced that they will report fiscal year 2024 results on Mar 13, 2025
Reported Earnings • Mar 15Full year 2023 earnings released: EPS: €1.12 (vs €7.88 in FY 2022)Full year 2023 results: EPS: €1.12 (down from €7.88 in FY 2022). Revenue: €3.87b (down 32% from FY 2022). Net income: €209.9m (down 86% from FY 2022). Profit margin: 5.4% (down from 27% in FY 2022). The decrease in margin was driven by lower revenue. Revenue is forecast to stay flat during the next 3 years compared to a 5.7% growth forecast for the Chemicals industry in Italy. Over the last 3 years on average, earnings per share has increased by 46% per year but the company’s share price has only increased by 16% per year, which means it is significantly lagging earnings growth.
Valuation Update With 7 Day Price Move • Jan 08Investor sentiment deteriorates as stock falls 15%After last week's 15% share price decline to €13.77, the stock trades at a forward P/E ratio of 15x. Average forward P/E is 16x in the Chemicals industry in Europe. Total returns to shareholders of 49% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €8.84 per share.
공시 • Nov 24+ 1 more updateK+S Aktiengesellschaft to Report Q3, 2024 Results on Nov 14, 2024K+S Aktiengesellschaft announced that they will report Q3, 2024 results at 7:00 AM, Central European Standard Time on Nov 14, 2024
Reported Earnings • Nov 15Third quarter 2023 earnings released: €0.25 loss per share (vs €1.48 profit in 3Q 2022)Third quarter 2023 results: €0.25 loss per share (down from €1.48 profit in 3Q 2022). Revenue: €880.8m (down 40% from 3Q 2022). Net loss: €47.6m (down 117% from profit in 3Q 2022). Revenue is expected to decline by 3.5% p.a. on average during the next 3 years, while revenues in the Chemicals industry in Italy are expected to grow by 6.1%. Over the last 3 years on average, earnings per share has increased by 69% per year but the company’s share price has only increased by 30% per year, which means it is significantly lagging earnings growth.
공시 • Aug 15K+S Aktiengesellschaft to Report Q1, 2024 Results on May 13, 2024K+S Aktiengesellschaft announced that they will report Q1, 2024 results at 7:00 AM, Central European Standard Time on May 13, 2024
Reported Earnings • Aug 13Second quarter 2023 earnings released: €0.24 loss per share (vs €1.94 profit in 2Q 2022)Second quarter 2023 results: €0.24 loss per share (down from €1.94 profit in 2Q 2022). Revenue: €825.8m (down 45% from 2Q 2022). Net loss: €45.3m (down 112% from profit in 2Q 2022). Revenue is expected to decline by 4.1% p.a. on average during the next 3 years, while revenues in the Chemicals industry in Europe are expected to grow by 3.1%. Over the last 3 years on average, earnings per share has increased by 76% per year but the company’s share price has only increased by 44% per year, which means it is significantly lagging earnings growth.
공시 • Aug 11K+S Aktiengesellschaft to Report Q2, 2024 Results on Aug 14, 2024K+S Aktiengesellschaft announced that they will report Q2, 2024 results on Aug 14, 2024
New Risk • Jul 20New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Italian stocks, typically moving 4.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings are forecast to decline by an average of 78% per year for the foreseeable future. Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Share price has been volatile over the past 3 months (4.8% average weekly change). Profit margins are more than 30% lower than last year (26% net profit margin).
Upcoming Dividend • May 04Upcoming dividend of €1.00 per share at 5.8% yieldEligible shareholders must have bought the stock before 11 May 2023. Payment date: 15 May 2023. Payout ratio is a comfortable 13% and this is well supported by cash flows. Trailing yield: 5.8%. Within top quartile of Italian dividend payers (5.2%). Higher than average of industry peers (3.9%).
Reported Earnings • Mar 16Full year 2022 earnings released: EPS: €7.88 (vs €11.35 in FY 2021)Full year 2022 results: EPS: €7.88 (down from €11.35 in FY 2021). Revenue: €5.68b (up 77% from FY 2021). Net income: €1.51b (down 31% from FY 2021). Profit margin: 27% (down from 68% in FY 2021). The decrease in margin was driven by higher expenses. Revenue is expected to decline by 6.9% p.a. on average during the next 3 years, while revenues in the Chemicals industry in Europe are expected to grow by 2.6%. Over the last 3 years on average, earnings per share has increased by 79% per year but the company’s share price has only increased by 45% per year, which means it is significantly lagging earnings growth.
공시 • Jan 27K+S Aktiengesellschaft (XTRA:SDF) agreed to acquire 75% stake in Fertilizer business of Industrial Commodities Holdings (Pty) Ltd (ICH).K+S Aktiengesellschaft (XTRA:SDF) agreed to acquire 75% stake in Fertilizer business of Industrial Commodities Holdings (Pty) Ltd (ICH) on January 26, 2023. The new business will operate under the name Fertiva (Pty) Ltd. The balance of 25% of shares in Fertiva will be held by two former ICH shareholders, who will now be a part of the Fertiva management team. The closing of the transaction remains subject to the fulfillment of a number of conditions, including obtaining required regulatory approvals and is expected to close during the second quarter of 2023.
공시 • Jan 22K+S Aktiengesellschaft Appoints Carin-Martina Tröltzsch as Member of the Board of Executive Directors, Effective March 15, 2023The Supervisory Board of K+S Aktiengesellschaft has appointed Dr. Carin-Martina Tröltzsch as a further member of the Board of Executive Directors of the Company. She will assume her position at K+S on March 15, 2023. Dr. Christian H. Meyer, who was already appointed as the new Chief Financial Officer by the Supervisory Board of the Company in February of last year, will also take up his position on March 15, 2023, and will be responsible for the management and further development of the finance area at K+S. Dr. Burkhard Lohr, Chairman of the Board of Executive Directors, had assumed this role on a transitional basis in recent months.
공시 • Nov 13K+S Aktiengesellschaft to Report Q3, 2022 Results on Nov 14, 2023K+S Aktiengesellschaft announced that they will report Q3, 2022 results at 7:00 AM, Central European Standard Time on Nov 14, 2023
Reported Earnings • Aug 12Second quarter 2022 earnings released: EPS: €1.93 (vs €0.78 in 2Q 2021)Second quarter 2022 results: EPS: €1.93 (up from €0.78 in 2Q 2021). Revenue: €1.51b (up 127% from 2Q 2021). Net income: €370.3m (up 147% from 2Q 2021). Profit margin: 25% (up from 23% in 2Q 2021). Over the next year, revenue is forecast to grow 16%, compared to a 14% growth forecast for the industry in Italy. Over the last 3 years on average, earnings per share has increased by 65% per year but the company’s share price has only increased by 16% per year, which means it is significantly lagging earnings growth.
공시 • Aug 12K+S Aktiengesellschaft to Report Q2, 2023 Results on Aug 10, 2023K+S Aktiengesellschaft announced that they will report Q2, 2023 results on Aug 10, 2023
Reported Earnings • May 13First quarter 2022 earnings releasedFirst quarter 2022 results: Revenue: €1.21b (up 65% from 1Q 2021). Net income: €310.9m (up 44% from 1Q 2021). Profit margin: 26% (down from 29% in 1Q 2021). Over the next year, revenue is forecast to grow 46%, compared to a 17% growth forecast for the industry in Italy.
공시 • May 12K+S Aktiengesellschaft to Report Q1, 2023 Results on May 09, 2023K+S Aktiengesellschaft announced that they will report Q1, 2023 results on May 09, 2023
Upcoming Dividend • May 06Upcoming dividend of €0.20 per shareEligible shareholders must have bought the stock before 13 May 2022. Payment date: 17 May 2022. Trailing yield: 0.6%. Lower than top quartile of Italian dividend payers (4.8%). Lower than average of industry peers (3.3%).
Valuation Update With 7 Day Price Move • Apr 11Investor sentiment improved over the past weekAfter last week's 17% share price gain to €32.67, the stock trades at a forward P/E ratio of 5x. Average forward P/E is 15x in the Chemicals industry in Europe. Total returns to shareholders of 84% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €33.62 per share.
Buying Opportunity • Mar 29Now 22% undervaluedOver the last 90 days, the stock is up 67%. The fair value is estimated to be €32.95, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 18% per annum over the last 3 years. The company has become profitable over the last year.
Valuation Update With 7 Day Price Move • Mar 21Investor sentiment improved over the past weekAfter last week's 18% share price gain to €27.62, the stock trades at a forward P/E ratio of 5x. Average forward P/E is 15x in the Chemicals industry in Europe. Total returns to shareholders of 66% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €33.10 per share.
Reported Earnings • Mar 11Full year 2021 earnings: EPS in line with analyst expectations despite revenue beatFull year 2021 results: EPS: €11.36 (up from €9.88 loss in FY 2020). Revenue: €3.21b (up 32% from FY 2020). Net income: €2.17b (up €4.06b from FY 2020). Profit margin: 68% (up from net loss in FY 2020). The move to profitability was primarily driven by lower expenses. Revenue exceeded analyst estimates by 2.3%. Over the next year, revenue is forecast to grow 28%, compared to a 12% growth forecast for the industry in Italy. Over the last 3 years on average, earnings per share has increased by 8% per year but the company’s share price has increased by 17% per year, which means it is tracking significantly ahead of earnings growth.
Valuation Update With 7 Day Price Move • Mar 02Investor sentiment improved over the past weekAfter last week's 16% share price gain to €23.69, the stock trades at a forward P/E ratio of 4x. Average forward P/E is 16x in the Chemicals industry in Europe. Total returns to shareholders of 45% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €26.40 per share.
Reported Earnings • Nov 15Third quarter 2021 earnings released: EPS €6.64 (vs €10.26 loss in 3Q 2020)Third quarter 2021 results: Revenue: €746.3m (down 9.2% from 3Q 2020). Net income: €1.27b (up €3.23b from 3Q 2020). Over the last 3 years on average, earnings per share has fallen by 43% per year but the company’s share price has only fallen by 5% per year, which means it has not declined as severely as earnings.
Reported Earnings • Aug 18Second quarter 2021 earnings released: EPS €0.78 (vs €0.019 loss in 2Q 2020)The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: €664.2m (up 13% from 2Q 2020). Net income: €149.9m (up €153.6m from 2Q 2020). Profit margin: 23% (up from net loss in 2Q 2020). The move to profitability was primarily driven by lower expenses. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 102 percentage points per year, which is a significant difference in performance.
Reported Earnings • May 14First quarter 2021 earnings released: EPS €1.13 (vs €0.33 loss in 1Q 2020)The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2021 results: Revenue: €733.3m (up 13% from 1Q 2020). Net income: €215.7m (up €278.9m from 1Q 2020). Profit margin: 29% (up from net loss in 1Q 2020). The move to profitability was primarily driven by lower expenses. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 104 percentage points per year, which is a significant difference in performance.
Is New 90 Day High Low • Jan 04New 90-day high: €8.44The company is up 19% from its price of €7.10 on 06 October 2020. The Italian market is up 13% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 6.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €4.87 per share.
Is New 90 Day High Low • Nov 27New 90-day high: €7.81The company is up 26% from its price of €6.19 on 28 August 2020. The Italian market is up 10.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 4.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €18.95 per share.
Reported Earnings • Nov 13Third quarter 2020 earnings released: €10.26 loss per shareThe company reported a poor third quarter result with increased losses and weaker revenues and control over expenses. Third quarter 2020 results: Revenue: €821.7m (down 9.2% from 3Q 2019). Net loss: €1.96b (loss widened €1.91b from 3Q 2019). Over the last 3 years on average, earnings per share has fallen by 132% per year but the company’s share price has only fallen by 32% per year, which means it has not declined as severely as earnings.
Analyst Estimate Surprise Post Earnings • Nov 13Revenue misses expectationsRevenue missed analyst estimates by 1.4%. Over the next year, revenue is forecast to grow 3.2% while the growth in Chemicals industry in Italy is expected to stay flat.
Is New 90 Day High Low • Sep 22New 90-day low: €5.25The company is down 10.0% from its price of €5.85 on 24 June 2020. The Italian market is down 1.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 10.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €16.81 per share.